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Incidence and In-Hospital Mortality of Acute Kidney Injury (AKI)
and Dialysis-Requiring AKI (AKI-D) After Cardiac Catheterization
in the National Inpatient Sample
Jeremiah R. Brown, PhD, MS; Michael E. Rezaee, MPH; Elizabeth L. Nichols, MS; Emily J. Marshall, MPH; Edward D. Siew, MD, MSCI;
Michael E. Matheny, MD, MSc, MPH
Background-—Acute kidney injury (AKI) and dialysis-requiring AKI (AKI-D) are common, serious complications of cardiac
procedures.
Methods and Results-—We evaluated 3 633 762 (17 765 214 weighted population) cardiac catheterization or percutaneous
coronary intervention (PCI) hospital discharges from the nationally representative National Inpatient Sample to determine annual
population incidence rates for AKI and AKI-D in the United States from 2001 to 2011. Odds ratios for both conditions and
associated in-hospital mortality were calculated for each year in the study period using multiple logistic regression. The number of
cardiac catheterization or PCI cases resulting in AKI rose almost 3-fold from 2001 to 2011. The adjusted odds of AKI and AKI-D per
year among cardiac catheterization and PCI patients were 1.11 (95% CI: 1.10–1.12) and 1.01 (95% CI: 0.99–1.02), respectively.
Most importantly, in-hospital mortality significantly decreased from 2001 to 2011 for AKI (19.6–9.2%) and AKI-D (28.3–19.9%),
whereas odds of associated in-hospital mortality were 0.50 (95% CI: 0.45–0.56) and 0.70 (95% CI: 0.55–0.93) in 2011 versus
2001, respectively. The population-attributable risk of mortality for AKI and AKI-D was 25.8% and 3.8% in 2001 and 41.1% and 6.5%
in 2011, respectively. Males and females had similar patterns of AKI increase, although males outpaced females.
Conclusions-—The Incidence of AKI among cardiac catheterization and PCI patients has increased sharply in the United States, and
this should be addressed by implementing prevention strategies. However, mortality has significantly declined, suggesting that
efforts to manage AKI and AKI-D after cardiac catheterization and PCI have reduced mortality. ( J Am Heart Assoc. 2016;5:
e002739 doi: 10.1161/JAHA.115.002739)
Key Words: acute kidney injury • acute renal failure • glomerular filtration rate • renal failure
P ercutaneous coronary intervention (PCI) and other typesof cardiac catheterization (e.g., diagnostic procedures of
the heart) are increasingly prevalent in the United States,
accounting for over 2 000 000 procedures annually.1,2 This
increase has been driven by the substitution of cardiac
surgeries for less-invasive catheterization, increased hospital
catheterization capacity, and a greater emphasis on evidence-
based care for noncomplex lesions.2–5 One of the most
common complications of cardiac catheterization and PCI is
acute kidney injury (AKI). Cardiac catheterization or PCI
patients who develop AKI have an increased risk of cardio-
vascular events, end-stage renal disease, all-cause mortality,
increased length of stay, and additional acute care costs of
$7500.6–8 AKI severity is positively associated with mor-
bidity and mortality, and dialysis-requiring AKI (AKI-D) is
associated with the highest rates of morbidity and mortality
among patients with post-procedural AKI.9,10 The primary
cause of AKI and AKI-D in cardiac catheterization or PCI
patients is the use of nephrotoxic, iodinated contrast media
for cardiac imaging. Contrast-induced AKI occurs in 3% to 14%
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of cardiac catheterization or PCI patients and is the third-most
common cause of AKI in hospitalized patients.11–13 The 2
primary mechanisms by which contrast media can cause
nephrotoxicity are vasoconstriction/ischemic injury and
direct toxicity to renal tubular cells.14 These pathways lead
to acute tubular necrosis and renal cell apoptosis, causing
renal dysfunction. Because of increased use and complexity of
cardiac catheterization and PCI requiring large volumes of
contrast media, we hypothesized that incidence of AKI and
AKI-D has increased among patients undergoing these
procedures. Using a nationally representative sample and
census data, we calculated the population-based incidence
and associated in-hospital mortality of AKI and AKI-D among
cardiac catheterization or PCI patients in the United States
from 2001 to 2011.
Methods
We used National Inpatient Sample (NIS) discharge data from
2001 to 2011. The NIS is a yearly nationally-representative,
stratified sample of 20% of community-based hospitals in
the United States, making it the largest US all-payer inpatient
database available to researchers.15 Thirty-three states (986
hospitals) contributed over 7 400 000 discharge records to
this database in 2001. The NIS grew to 46 states, 1049
hospitals, and over 8 000 000 discharge records by 2011.
The Committee for the Protection of Human Subjects at
Dartmouth College waived required approval for this study
because the NIS contains no protected health information and
is publicly available.
Our study cohort consisted of hospitalizations requiring
PCI or cardiac catheterization during the study period.
International Classification of Diseases, Ninth Revision, Clin-
ical Modification (ICD-9-CM) procedure and diagnosis codes
were used to identify and describe these patients. We defined
PCI or cardiac catheterization cases using any of the following
ICD-9-CM codes: 0066 (percutaneous transluminal coronary
angioplasty); 3601 to 3609 (operations on vessels of heart);
3722 to 3723 (diagnostic procedures on heart and peri-
cardium); or 8853 to 8857 (angiocardiography using contrast
material).
Primary outcomes were occurrence of AKI and AKI-D and
in-hospital mortality postcardiac catheterization or PCI. Cases
of AKI were identified using the following ICD-9-CM codes for
acute renal failure: 584.5 (with tubular necrosis); 584.6 (with
lesion of renal cortical necrosis); 584.7 (with lesion of renal
medullary necrosis); 584.8 (other specified pathological lesion
in kidney); or 584.9 (unspecified). Cases of AKI-D were
defined as an AKI diagnosis plus a co-listed code for
hemodialysis, hemofiltration, or peritoneal dialysis (V45.1,
V56.0, 39.95, V56.1, and 54.98). Records with hemodialysis,
hemofiltration, or peritoneal dialysis procedure codes without
an AKI diagnosis code were excluded from the analysis, as in
similar investigations.16 Patients with arteriovenous fistula
creation or revision procedure codes (39.27, 39.42, 39.43,
and 39.93) were excluded from analysis to increase sensitivity
and specificity for acute dialysis procedures.17
In our model, we accounted for co-occurring conditions,
age, sex, cardiac procedure characteristics, and hospital
utilization practices in adjusted analyses (we hypothesized no
difference in sex). NIS comorbidity indicators were used to
identify these co-occurring conditions (congestive heart
failure, pulmonary circulation disorders, peripheral vascular
disease, hypertension, other neurological disorders, chronic
pulmonary disease, diabetes without chronic complications,
diabetes with chronic complications, renal failure, obesity,
fluid and electrolyte disorders, blood loss anemia, and
deficiency anemias). Specific ICD-9-CM codes used to identify
co-occurring conditions are available for review.18 For
adjustment for cardiac procedure characteristics, we also
identified sepsis cases (038.x, 112.5, 112.81, 020.2, 790.7,
and 785.59) and the number of stents placed during
angioplasty, which was considered to account for coronary
vessel disease severity and procedure intensity (0045–0048).
Lastly, our model was adjusted for yearly median length of
stay and the proportion of patients discharged to skilled
nursing facilities. We adjusted for discharge to skilled nursing
facilities and median lengths of stay to account for potential
changes in discharge practices over time and/or between
hospitals. This model applies to both AKI and AKI-D. These
measures may be an indicator of unmeasured confounding
attributed to unmeasured comorbidities. Additionally, length
of stay has declined over time, and discharge to skilled
nursing facilities has been shown to increase over time.19
We calculated the population incidence of AKI and AKI-D
for patients who underwent cardiac catheterization or PCI in
the United States from 2001 to 2011 by dividing the
unweighted number of discharges with AKI or AKI-D by the
annual US population (according to the U.S. Census
Bureau).17 Incidence estimates were stratified by sex and
age for subgroup analysis. We then used multiple logistic
regression to determine the odds of AKI, AKI-D, and
corresponding in-hospital mortality. To account for the
sampling frame and clustering, we applied population weights
to the model. Crude and adjusted models were used to
estimate the odds of AKI and AKI-D per a 1-year increase. We
performed the same analysis for sex and age subgroups.
Because the NIS has been adding data from more and more
states over the years, including during our study period, we
adjusted for covariates over time to counteract the addition of
these states. We used crude and adjusted models to estimate
the odds of mortality for each year, with 2001 as a reference.
Adjusted models accounted for age, sex, race, congestive
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heart failure, pulmonary circulation disorders, peripheral
vascular disease, hypertension, other neurological disorders,
chronic pulmonary disease, diabetes without chronic compli-
cations, diabetes with chronic complications, renal failure,
obesity, fluid and electrolyte disorders, blood loss anemia,
deficiency anemias, sepsis, and cardiac catheterization. Using
these models, we calculated the population-attributable risk
of death for PCI or cardiac catheterization patients during
hospitalization for AKI and AKI-D. Population-attributable risk
approximates the proportion of patient deaths that could be
prevented if a condition (e.g. AKI-D) and its associated
complications are avoided. All data were analyzed using SAS
software (volume 9.3; SAS Institute Inc., Cary, NC) and
weighted at the discharge level to account for the NIS
sampling schema.
Results
Yearly characteristics for cardiac catheterization and PCI
patients are displayed in Table 1. Sample sizes are
unweighted, whereas percentages are population-weighted.
The proportion of patients undergoing only cardiac catheter-
ization remained stable (56.9–56.0%), whereas the proportion
of patients undergoing only PCI decreased (6.2–3.3%) from
2001 to 2011. The proportion of patients undergoing both
procedures grew (36.9–40.7%) from 2001 to 2011. Most
characteristics of cardiac catheterization and PCI patients
changed across study years, except sex, age, and blood loss
anemia. The largest increases occurred in patients with
hypertension (51.6–71.8%), diabetes without chronic compli-
cations (23.1–30.5%), obesity (7.72–16.8%), renal failure
predceing surgery (3.6–15.2%), electrolyte disorders (7.0–
17.3%), and deficiency anemias (6.3–14.2%) from 2002 to
2011.
We identified 184 752 (894 815 population weighted; 273
per 1 000 000) hospitalizations requiring cardiac catheteri-
zation or PCI with a subsequent diagnosis of AKI over the
study period.20 From 2001 to 2011, the number of cases of
cardiac catheterization or PCI resulting in AKI rose almost 3-
fold in the United States, from 8789 to 26 851 (44 158–
127 380 population weighted; 155–416 per 1 000 000;
Figure 1). However, the AKI incidence among cardiac
catheterization or PCI patients did not increase uniformly
every year. AKI incidence declined substantially in 2010. AKI-
D incidence had similar patterns of overall growth and decline
in 2010 (Figure 2). Unadjusted logistic regression showed
that patients had 1.17 (95% CI, 1.16–1.18) times the odds of
AKI per 1-year increase (Table 2). After adjustment for
patient, cardiac procedure, and hospital characteristics, the
odds of developing AKI were 1.11 times the previous year
(95% CI, 1.10–1.12). AKI incidence increased similarly for menTa
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and women over the study period. However, the increase in
AKI incidence for men outpaced that of women (Figure 3).
Across age groups, AKI incidence increased similarly, except
for the 0 to 19 and 20 to 40 age groups, in which AKI
incidence plateaued toward the study period’s end (Fig-
ure 4).
In-hospital mortality for cardiac catheterization or PCI
patients with AKI decreased from 19.6% in 2001 to 9.2% in
2011 (unadjusted odds ratio [OR], 0.42; 95% CI, 0.38–0.46;
adjusted OR, 0.50; 95% CI, 0.45–0.56; Table 3). Despite a
decrease in yearly mortality rates for these patients (adjusted
OR=0.91 in 2001 to adjusted OR=0.50 in 2011; Table 3), the
number dying after developing AKI after cardiac catheterization
or PCI increased over the study period (population-attributable
risk [PAR]=25.8 in 2001 to PAR=41.1 in 2011; Table 4).
However, this increase was masked by an even larger yearly
increase in total AKI incidence after cardiac catheterization or
PCI. The population-attributable risk of mortality associated
with developing AKI after cardiac catheterization or PCI was
25.8% in 2001 compared to 41.1% in 2011 (Table 4).
Because discharges to skilled nursing facilities remained
static over the study period, it is unlikely that variability in
hospital characteristics impacted mortality estimates. Length
of stay decreased among AKI patients in the study period
from a median of 11 (interquartile range [IQR], 7–19) days
in 2001 to 7 (IQR, 4–13) days in 2011. This may indicate
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Figure 1. AKI incidence: population incidence of acute kidney
injury among cardiac catheterization and percutaneous coronary
intervention patients in the United States from 2001 to 2011. AKI
indicates acute kidney injury.
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Figure 2. AKI-D incidence: population incidence of dialysis-
requiring acute kidney injury among cardiac catheterization and
percutaneous coronary intervention patients in the United States
from 2001 to 2011. AKI-D indicates dialysis-requiring acute
kidney injury.
Table 2. Crude and Adjusted ORs of Developing AKI and AKI-
D Relative to the Previous Year Among Patients Undergoing
Cardiac Catheterization or PCI in the United States
Population at Risk
Crude OR/Year Adjusted OR/Year
95% CI 95% CI
AKI
Overall, per y 1.17 (1.16–1.18) 1.11 (1.10–1.12)
Age groups, y
0 to 19 1.05 (0.99–1.10) 1.02 (0.97–1.08)
20 to 44 1.24 (1.22–1.26) 1.19 (1.17–1.20)
45 to 64 1.20 (1.18–1.21) 1.14 (1.13–1.15)
65 to 74 1.16 (1.15–1.18) 1.11 (1.10–1.12)
75+ 1.15 (1.14–1.17) 1.09 (1.08–1.10)
Sex
Male 1.18 (1.17–1.19) 1.12 (1.11–1.13)
Female 1.16 (1.15–1.17) 1.10 (1.10–1.11)
AKI-D
Overall, per y 1.11 (1.09–1.13) 1.01 (0.99–1.02)
Age groups
0 to 19 1.01 (0.92–1.10) 0.98 (0.90–1.08)
20 to 44 1.16 (1.12–1.20) 1.07 (1.03–1.10)
45 to 64 1.15 (1.13–1.17) 1.05 (1.03–1.07)
65 to 74 1.12 (1.10–1.14) 1.02 (1.00–1.04)
75+ 1.07 (1.05–1.09) 0.95 (0.93–0.97)
Sex
Male 1.12 (1.10–1.14) 1.01 (0.99–1.03)
Female 1.10 (1.08–1.12) 1.01 (0.99–1.02)
Please note that we use survey methods with population weights and adjust for age, sex,
race, congestive heart failure, pulmonary circulation disorders, peripheral vascular
disease, hypertension, other neurological disorders, chronic pulmonary disease, diabetes
without chronic complications, diabetes with chronic complications, renal failure,
obesity, fluid and electrolyte disorders, blood loss anemia, deficiency anemias, sepsis,
cardiac catheterization, yearly median length of stay, and the proportion of patients
discharged to skilled nursing facilities. AKI indicates acute kidney injury; AKI-D, dialysis-
requiring acute kidney injury; OR, odds ratio; PCI, percutaneous coronary intervention.
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more-efficient care management after cardiac catheterization
or PCI, where AKI may have been resolved more quickly and
patients discharged earlier.
AKI-D among cardiac catheterization or PCI patients
accounted for 14 896 (71 368 population-weighted) hospi-
talizations during the study period (22 per 1 000 000). From
2001 to 2011, the number of cases of cardiac catheterization
or PCI resulting in AKI-D more than doubled in the United
States, from 877 to 1915 (4435–9047 population-weighted;
16–30 per 1 000 000; Figure 1). At-risk patients had 1.11
(95% CI, 1.09–1.13) times the odds of AKI-D per 1-year
increase. After adjustment for patient, cardiac procedure, and
hospital characteristics, odds for developing AKI-D were only
1.01 times the previous year (95% CI, 0.99–1.02) and were no
longer statistically significant (Table 2). AKI-D incidence
increased similarly in men and women and across age groups,
though incidence was more variable by age (Figures 3 and 5).
In-hospital mortality for postcardiac catheterization or PCI
AKI-D patients decreased from 28.3% in 2001 to 19.9% in
2011 (unadjusted OR=0.63; 95% CI, 0.50–0.80; adjusted
OR=0.70; 95% CI, 0.55–0.93; Table 3). The number who died
after developing AKI-D postcardiac catheterization or PCI
actually increased during the study period (1256 deaths in
2001 to 1801 deaths in 2011), but was obscured by a larger
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Figure 3. AKI and AKI-D incidence by sex: population incidence
of acute kidney injury and dialysis-requiring acute kidney injury
among cardiac catheterization and percutaneous coronary inter-
vention patients by sex in the United States from 2001 to 2011.
AKI indicates acute kidney injury; AKI-D, dialysis-requiring acute
kidney injury.
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Figure 4. AKI incidence by age: population incidence of acute
kidney injury among cardiac catheterization and percutaneous
coronary intervention patients by age group in the United States
from 2001 to 2011. AKI indicates acute kidney injury.
Table 3. Crude and Adjusted ORs of In-Hospital Mortality
Among AKI and AKI-D Patients Undergoing Cardiac
Catheterization or PCI in the United States
Year
Crude OR Adjusted OR
95% CI 95% CI
Odds of mortality—AKI
2001 Referent
2002 0.89 (0.80–0.98) 0.91 (0.82–1.02)
2003 0.79 (0.72–0.80) 0.89 (0.80–0.98)
2004 0.68 (0.62–0.76) 0.73 (0.65–0.81)
2005 0.61 (0.55–0.68) 0.66 (0.59–0.74)
2006 0.56 (0.51–0.61) 0.66 (0.60–0.73)
2007 0.51 (0.46–0.67) 0.61 (0.54–0.68)
2008 0.50 (0.45–0.55) 0.59 (0.53–0.66)
2009 0.44 (0.40–0.49) 0.54 (0.49–0.60)
2010 0.41 (0.37–0.45) 0.50 (0.45–0.56)
2011 0.42 (0.38–0.46) 0.50 (0.45–0.56)
Odds of mortality—AKI-D
2001 Referent
2002 1.02 (0.81–1.30) 1.16 (0.90–1.49)
2003 0.82 (0.64–1.04) 0.85 (0.65–1.11)
2004 0.72 (0.57–0.91) 0.74 (0.58–0.96)
2005 0.74 (0.58–0.95) 0.75 (0.57–0.97)
2006 0.72 (0.57–0.91) 0.82 (0.64–1.06)
2007 0.73 (0.58–0.92) 0.78 (0.61–1.00)
2008 0.78 (0.61–1.00) 0.80 (0.62–1.04)
2009 0.69 (0.55–0.87) 0.77 (0.60–0.99)
2010 0.64 (0.50–0.82) 0.71 (0.55–0.93)
2011 0.63 (0.50–0.80) 0.70 (0.55–0.93)
Please note that we use survey methods with population weights and adjust for age, sex,
race, congestive heart failure, pulmonary circulation disorders, peripheral vascular
disease, hypertension, other neurological disorders, chronic pulmonary disease, diabetes
without chronic complications, diabetes with chronic complications, renal failure,
obesity, fluid and electrolyte disorders, blood loss anemia, deficiency anemias, sepsis,
cardiac catheterization, yearly median length of stay, and the proportion of patients
discharged to skilled nursing facilities. AKI indicates acute kidney injury; AKI-D, dialysis-
requiring acute kidney injury; OR, odds ratio; PCI, percutaneous coronary intervention.
DOI: 10.1161/JAHA.115.002739 Journal of the American Heart Association 6
AKI and AKI-D After Cardiac Catheterization Brown et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
increase in yearly AKI-D incidence after cardiac catheteriza-
tion or PCI (adjusted yearly OR=1.01; Table 2). The popula-
tion-attributable risk of mortality associated with AKI-D after
cardiac catheterization or PCI rose from 3.8% in 2001 to 6.5%
in 2011. Median length of stay and proportion of patients
discharged to skilled nursing facilities remained static across
the study period. Figure 6 depicts the relatively unchanging
median length of stay over time.
Additionally, we calculated overall unweighted AKI and AKI-
D rates for (1) patients who have undergone cardiac
catheterization alone (AKI, 6.44%; AKI-D, 0.55%), (2) patients
who have undergone cardiac catheterization and PCI (AKI,
3.61%; AKI-D, 0.25%), and (3) patients who have undergone
PCI only (with no diagnostic catheterization immediately
beforehand [AKI, 2.60%; AKI-D, 0.23%]; Table 5). We observed
similar trends to the overall study, confirming increased rates
of both AKI and AKI-D among procedure subgroups for cardiac
catheterization only, PCI only, and cardiac catheterization with
PCI.
Discussion
Rates of AKI and AKI-D in this study population rose
significantly between 2001 and 2011. AKI incidence
increased 3-fold during the study period, whereas AKI-D
incidence increased 2-fold. Although the proportion of AKI and
AKI-D patients dying in-hospital decreased, both the absolute
number of deaths and the population-attributable risk of death
for AKI and AKI-D increased from 2001 to 2011. Over 40% of
deaths after cardiac catheterization or PCI occur in combina-
tion with AKI, whereas 6.5% occur in combination with AKI-D.
Based on these findings, a significant opportunity exists to
prevent and manage AKI and AKI-D among cardiac catheter-
ization and PCI patients in the United States.
Epidemiological investigations indicate that AKI and AKI-D
incidence is increasing among hospitalized patients.16,17,21,22
Using the NIS, Hsu found that the odds of developing AKI-D
increased by 10% annually among hospitalized patients in the
Table 4. Population-Attributable Risk of Mortality Associated
With AKI and AKI-D Patients Undergoing Cardiac
Catheterization or PCI in the United States, 2001 Through
2011
Year
Population-Attributable
Risk of Mortality AKI
Population-Attributable
Risk of Mortality AKI-D
2001 25.8 3.8
2002 28.6 4.4
2003 28.0 3.8
2004 28.9 4.4
2005 30.9 4.8
2006 31.0 5.1
2007 32.9 5.5
2008 36.8 6.0
2009 39.0 6.5
2010 37.8 6.1
2011 41.1 6.5
Please note that we use survey methods with population weights and adjust for age, sex,
race, congestive heart failure, pulmonary circulation disorders, peripheral vascular
disease, hypertension, other neurological disorders, chronic pulmonary disease, diabetes
without chronic complications, diabetes with chronic complications, renal failure,
obesity, fluid and electrolyte disorders, blood loss anemia, deficiency anemias, sepsis,
cardiac catheterization, yearly median length of stay, and the proportion of patients
discharged to skilled nursing facilities. AKI indicates acute kidney injury; AKI-D, dialysis-
requiring acute kidney injury; PCI, percutaneous coronary intervention.
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Figure 5. AKI-D incidence by age: population incidence of
dialysis-requiring acute kidney injury among cardiac catheteriza-
tion and percutaneous coronary intervention patients by age
group in the United States from 2001 to 2011. AKI-D indicates
dialysis-requiring acute kidney injury.
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Figure 6. Median length of stay: the median length of stay
remains relatively static from 2001 to 2011.
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United States between 2000 and 2009.17 Similarly, Lenihan
and Khera utilized the NIS to investigate the temporal
incidence of AKI and AKI-D, but among cardiac surgery and
elderly PCI patients.16,22 Compared to 1999, the adjusted
odds of AKI and AKI-D in 2008 for cardiac surgery patients
were 3.30 and 2.23, respectively.16 Among elderly PCI
patients (≥75 years), the adjusted odds of AKI and AKI-D in
2010 compared to 2002 were 1.87 and 0.20, respectively. We
found similar, though smaller, odds of AKI among cardiac
catheterization and PCI patients from 2001 to 2011 using NIS
discharge data. We expected slightly smaller odds of AKI in
our cohort, compared to the Lenihan and Khera studies,
because cardiac surgery and elderly PCI patients have an
increased risk of AKI attributed to age and comorbidity
burden.16,22 Unlike other studies, we found that cardiac
catheterization and PCI patients did not have significantly
different odds of AKI-D in 2011 versus 2001, despite the
doubling of such cases over the study period.
Not all studies show AKI and AKI-D increases in the United
States. In an analysis of acute myocardial infarction patients
across 56 health care centers, Amin found that AKI incidence
declined from 27% to 20% from 2000 to 2008.23 However,
this study reported trends in hospital-based incidences for
patients at experienced treatment centers, not all of which
underwent coronary angiography. Nevertheless, these results
highlight the importance of studying trends across different
populations to identify modifiable risk factors to prevent AKI
and AKI-D.24
There are several possible explanations for our observed
increase in AKI and AKI-D incidence between 2001 and 2011.
Whereas PCI patient age distribution remained relatively
constant, we did notice a trend toward increasing comorbidity
burden over time, including specific AKI risk factors such as
hypertension, obesity, and diabetes. However, adjusting for
these risk factors only partially accounted for the observed
growth. Another potential contributor is the increasing
complexity of procedures being performed, whether attributed
to the complexity of the procedures themselves or to
increasingly complex settings. Improvements in sensitivity
attributed to increasing provider awareness over time may
have also partially explained the observed temporal increase
in AKI incidence.25–30 Recently, Grams et al. demonstrated an
increase in sensitivity of administrative codes for AKI from
10% to 24% over a similar time interval as our study with a
high, constant specificity.29,31–33 Though this increase in code
sensitivity likely accounts for some of the increase in AKI,
research that uses consistent creatinine-based definitions for
AKI over the duration of their studies (rather than adminis-
trative codes) has suggested that the increase in AKI
incidence is real.34 Such consistent definitions provide
argument against a higher false-positive rate. Additionally,
assuming 10% of AKI cases were coded correctly at the
beginning of our study period and a constant population-
based incidence rate over time, an increase in sensitivity
would also not explain the observed increase in AKI-D, which
is a condition more tightly linked to billing with lower rates of
misclassification.
Evidence also suggests that clinicians may be taking a
more aggressive approach to dialysis. Siddiqui et al. found
that median time to dialysis after major elective surgery
decreased from 5 to 2 days, indicating that changing practice
patterns may be playing a role.35 Inclusion of additional
Table 5. Incidence of AKI and AKI-D by Procedure Type From 2001 to 2011
AKI AKI-D
Catheterization Only (%) PCI Only (%) Catheterization and PCI (%) Catheterization Only (%) PCI Only (%) Catheterization and PCI (%)
2001 3.06 1.24 1.71 0.30 0.18 0.17
2002 3.71 1.14 1.98 0.35 0.12 0.18
2003 4.03 1.37 2.05 0.37 0.13 0.17
2004 4.42 1.72 2.32 0.46 0.21 0.19
2005 5.30 2.07 2.54 0.49 0.17 0.19
2006 5.76 1.99 2.71 0.55 0.15 0.18
2007 6.82 2.79 3.55 0.59 0.23 0.24
2008 8.53 3.65 4.50 0.69 0.24 0.27
2009 10.18 5.15 5.89 0.78 0.39 0.39
2010 10.73 6.66 6.86 0.78 0.54 0.43
2011 11.88 8.10 7.55 0.88 0.68 0.49
Total 6.44 2.60 3.61 0.55 0.23 0.25
Please note that these are rates based on unweighted data. AKI indicates acute kidney injury; AKI-D, dialysis-requiring acute kidney injury.
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hospitals in the NIS over the study period (n=63) may have
also contributed to the observed increase in AKI cases. For
cardiac catheterization and PCI procedures, the contrast
media used for imaging is nephrotoxic and was likely a
significant driver behind the increasing rates of AKI and AKI-D
observed here from 2001 to 2011. The proportion of AKI and
AKI-D patients undergoing dual cardiac catheterization and
PCI in our study grew by 6% and 4%, respectively.
Several studies have demonstrated that the proportion of
AKI and AKI-D patients experiencing in-hospital mortality is
declining in the United States.16,17,22 However, the number of
AKI and AKI-D cases is growing at an alarming rate, masking a
smaller, yet significant, absolute mortality increase for these
patients. For example, Khera et al. found that the adjusted
odds of mortality among elderly PCI patients who developed
AKI was 0.74 in 2010 compared to 2002, a 11.6% reduction in
the proportion of AKI patients experiencing in-hospital
mortality.22 However, the raw number of patient deaths for
this population increased more than 3-fold during the same
time.22 Our analysis shows similar findings. Despite a
decrease in the odds of death among cardiac catheterization
or PCI patients with AKI or AKI-D from 2001 to 2011, the
population-attributable risk for mortality increased by 15.3%
and 2.7%, respectively. The proportion of potentially pre-
ventable deaths associated with AKI and AKI-D among cardiac
catheterization and PCI patients is on the rise.
Our main strength is the use of a large, multiyear,
nationally representative sample of cardiac catheterization
and PCI patients in the United States. The advantages of using
such a data set include increased statistical power, improved
outcome estimation accuracy, and wider generalizability of
results. In addition, our study was conducted on patients
undergoing cardiac catheterization or PCI, procedures that are
increasingly applied to patients at risk for AKI. Although some
reports indicate a decline in PCI use, catheterization capacity
in the United States continues to grow and the cumulative use
of PCI and other types of cardiac catheterization is on the rise,
as demonstrated in this analysis.36,37
Our study has a number of limitations. First, we used ICD-
9-CM administrative billing codes to identify patients in our
sample with a diagnosis of AKI or AKI-D, and the sensitivity of
these codes has increased over time, which could exaggerate
the increase in AKI incidence.29 Clinical or laboratory data,
such as serum creatinine, would have provided the most
accurate indicator for renal dysfunction had it been avail-
able.38 Given the known sensitivity limitations of administra-
tive codes for AKI, our results may underestimate its true
incidence.
Another limitation to our study is that the NIS also does
not provide granular detail about the underlying cause of AKI
post-PCI. Though AKI is most frequently caused by ischemia
and/or direct nephrotoxicity, there are many other causes
that we were unable to distinguish in this study, such as
medications, viruses, bacteria, systemic illnesses, extra- and
intrarenal obstructions, cardiorenal syndrome, hepatorenal
syndrome, systemic vasodilation, and volume depletion.39
Unmeasured variation between in- and outpatient medical
regimens may also have affected our results. Other factors,
such as atheroembolic disease, may have contributed. In
addition, the NIS database was limited in 2001 and may
under-represent a national sample for that year; however,
trends for AKI and AKI-D persist in subsequent years with
larger samples.
It is also possible that we did not account for a potential
underlying national decrease in in-hospital mortality, outside
of cardiac catheterization and PCI. It is possible that such a
trend would partially or wholly explain the decrease in
mortality that we found, but identifying determinants of
potential decreases in hospital mortality over time was
beyond the scope of this work.
Additionally, because of the causal relationship between
contrast media use and AKI, we assumed that cardiac
catheterization or PCI temporally preceded AKI or AKI-D.
Finally, despite using the same data abstraction code for
every year in the study period, there is a great deal of
comorbidity information missing for 2001. We are unsure why
this data are lacking.
Determining the incidence of, and mortality risk associated
with, AKI and AKI-D among cardiac catheterization or PCI
patients allows health care providers to understand the
clinical significance of this adverse outcome. Although
specific therapies for treatment of AKI are nonexistent,
hospitals with cardiac catheterization capability should invest
in implementing and standardizing prevention measures and
avoiding further kidney damage to address mortality in this
population.6,13,40–45 Moving forward, additional research is
needed to examine differences in AKI and AKI-D incidence
across additional cardiac catheterization or PCI patient
subgroups, including geographical and socioeconomic sub-
classes.
Our analysis demonstrates that incidence of AKI and AKI-D
among cardiac catheterization or PCI patients increased
drastically from 2001 to 2011. Over 40% of all deaths after
cardiac catheterization or PCI occur in combination with AKI.
Efforts to prevent AKI or AKI-D after cardiac catheterization or
PCI would result in significant reductions in mortality risk for
these patients.
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